![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-00996-y/MediaObjects/41392_2022_996_Fig1_HTML.png)
COVID-19 vaccine development: milestones, lessons and prospects | Signal Transduction and Targeted Therapy
![FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN](https://media.cnn.com/api/v1/images/stellar/prod/230109124641-moderna-bivalent-vaccine.jpg?c=original)
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
![LVHN Prepared to Give Moderna, Johnson & Johnson COVID-19 Vaccine Booster Shots to Eligible Populations Starting Oct. 25 LVHN Prepared to Give Moderna, Johnson & Johnson COVID-19 Vaccine Booster Shots to Eligible Populations Starting Oct. 25](https://www.lvhn.org/sites/default/files/2021-10/N17580%201200x628%20Colleague%20Booster%20Shots-blog.jpg)
LVHN Prepared to Give Moderna, Johnson & Johnson COVID-19 Vaccine Booster Shots to Eligible Populations Starting Oct. 25
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![COVID-19 Vaccine Booster Shots (3rd Dose)|Ministry of Health, Labour and Welfare, government of Japan|厚生労働省 COVID-19 Vaccine Booster Shots (3rd Dose)|Ministry of Health, Labour and Welfare, government of Japan|厚生労働省](https://www.mhlw.go.jp/content/booster.png)
COVID-19 Vaccine Booster Shots (3rd Dose)|Ministry of Health, Labour and Welfare, government of Japan|厚生労働省
![Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/article_feature/public/2023-02/bivalent-vaccine-g1422104879.jpg?h=f7026c63&itok=62rHr_a_)
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
![COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/ec1bbbc9-0d70-47da-a8ee-b885b4d05720/gr1.jpg)
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study - The Lancet Infectious Diseases
![Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7050e2_BoostersAdditionalPrimaryDoses_IMAGE_10Dec21_1200x627.jpg?_=35384)
Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021 | MMWR
![Vaccines | Free Full-Text | Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study Vaccines | Free Full-Text | Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study](https://pub.mdpi-res.com/vaccines/vaccines-09-01424/article_deploy/html/images/vaccines-09-01424-g002.png?1638436786)
Vaccines | Free Full-Text | Assessing Acceptability of COVID-19 Vaccine Booster Dose among Adult Americans: A Cross-Sectional Study
![Governor Tim Walz on X: "BIG NEWS: Minnesota will start administering Moderna and Johnson & Johnson booster shots, meaning eligible Minnesotans can maximize their protection against COVID-19! 💪 Find a booster shot Governor Tim Walz on X: "BIG NEWS: Minnesota will start administering Moderna and Johnson & Johnson booster shots, meaning eligible Minnesotans can maximize their protection against COVID-19! 💪 Find a booster shot](https://pbs.twimg.com/media/FCVFepNXsAImw7h.jpg)